Skip to content

When check bone density after starting AIs?

Page last modified on: September 23, 2008
Question from NY Nancy: How soon after starting an aromatase inhibitor should a woman have her bone density checked?
Answer —Mindy Goldman, M.D.: We frequently will recommend a baseline bone density right when someone is beginning an aromatase inhibitor. This allows us to have a guide as to what someone's bone density was before initiation of the drug. There is data that the aromatase inhibitors decrease bone density. But the most recent published data looking at fractures suggest that by two years of being on an aromatase inhibitor, there are no increased risks of fractures.

On Wednesday, July 21, 2004, our Ask-the-Expert Online Conference was called Managing Menopausal Symptoms. Mindy Goldman, M.D. and Marisa Weiss, M.D. answered your questions about how to manage menopausal symptoms, including hot flashes, vaginal dryness, loss of libido, and more.

The materials presented in these conferences do not necessarily reflect the views of breastcancer.org. A qualified healthcare professional should be consulted before using any therapeutic product or regimen discussed. All readers should verify all information and data before employing any therapies described here.

A production of LiveWorld, Inc.
Copyright 2008. All rights reserved.

wellness_dvd_promo

Email Updates

Stay informed about current research, online events, and more.

Please leave this field empty

Meet the Experts

Mindy Goldman, M.D.Mindy Goldman, M.D. is an OB/GYN physician specializing in the gynecology of breast cancer patients.

Marisa Weiss, M.D. is a radiation oncologist specializing in breast cancer and the founder, president, and guiding force behind Breastcancer.org.

Back to top

Breastcancer.org 7 East Lancaster Avenue, 3rd Floor Ardmore, PA 19003

Learn more about our commitment to your privacy

© 2009 Breastcancer.org - All rights reserved.

Breastcancer.org is a non-profit organization dedicated to providing information and community to those touched by this disease. Learn more about our commitment to providing complete, accurate, and private breast cancer information.